DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹2,969 Cr | ₹2,206 Cr | ₹2,369 Cr | ₹3,881 Cr | ₹2,861 Cr |
What is the latest Operating Profit of DIVIS LABORATORIES ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹2,969 Cr |
| Mar2024 | ₹2,206 Cr |
| Mar2023 | ₹2,369 Cr |
| Mar2022 | ₹3,881 Cr |
| Mar2021 | ₹2,861 Cr |
How is Operating Profit of DIVIS LABORATORIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,969 Cr | 34.59 | |
| Mar2024 | ₹2,206 Cr | -6.88 | |
| Mar2023 | ₹2,369 Cr | -38.96 | |
| Mar2022 | ₹3,881 Cr | 35.65 | |
| Mar2021 | ₹2,861 Cr | - | |
Compare Operating Profit of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹177,200.0 Cr | -0.6% | 2.2% | -0.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,048.0 Cr | 0.5% | 4.6% | 11.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,804.0 Cr | 3.2% | 8.1% | 43.9% | Stock Analytics | |
| CIPLA | ₹117,642.0 Cr | 1.1% | 5.6% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,368.0 Cr | -0.3% | 5.6% | -0.1% | Stock Analytics | |
| MANKIND PHARMA | ₹102,729.0 Cr | 1.1% | 8.2% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -0.6% |
2.2% |
-0.6% |
| SENSEX | 0.7% |
4.4% |
-5.6% |
You may also like the below Video Courses